MerinoTrial Profile Banner
MERINO Trial Profile
MERINO Trial

@MerinoTrial

Followers
1K
Following
128
Media
4
Statuses
152

RCT of Meropenem vs. Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to ESBL-producing E.coli and Klebsiella spp.

Brisbane, Queensland
Joined June 2015
Don't wanna be here? Send us removal request.
@MerinoTrial
MERINO Trial
8 years
We will be presenting the headline @MerinoTrial results in late breaker clinical trials session @ECCMID in Madrid - looking forward to sharing the results after years of hard work from many investigators in 9 countries @UQMedicine @UQ_News @ASIDANZ @davidantibiotic @padstamundo
5
30
78
@ABsteward
Antibiotic Steward Bassam Ghanem πŸ…±οΈCπŸ†”πŸ…ΏοΈπŸŒŸ
4 years
πŸ”₯πŸ”₯NEW πŸ”₯πŸ”₯ My new post a great collaboration w the amazing @IDstewardship Year In Review: Top✨ Non-COVID Infectious Diseases Articles Of 2021 18 high quality πŸ†” RCTs 6 RCTs @NEJM #Shorterisbetter #IDTwitter #MedEd #TwitteRx #ASPchat #SoMeDocs OthersπŸ€” https://t.co/wJtdjYJ0Gf
10
159
397
@AshaBowen
Asha Bowen
4 years
An @ASIDcrn clinical trial showing how future Trials for Resistant Gram Negative bacteria should be performed @MerinoTrial @davidantibiotic @padstamundo @IDWeek2021 @LodiseThomas
1
5
12
@ASP_PharmD
Brad Crane
4 years
A5. MERINO Trial @MerinoTrial was very helpful and well done. Answered real world, ID-related question/debate, low risk of big pharma bias (both generic), and changed my practice re: optimal Abx Rx for CRO-resistant E.coli/Klebsiella bacteremia. #ASPchat https://t.co/ozmIN8LJlw
Tweet card summary image
jamanetwork.com
This noninferiority trial compares the effects of piperacillin-tazobactam vs meropenem on mortality in patients with bloodstream infection caused by ceftriaxone-nonsusceptible Escherichia coli or...
@ASP_Chat
#ASPchat
4 years
Q5. πŸ“„πŸ˜ƒ What’s one of your favorite antimicrobial-related articles of all time?Β #ASPchat Β―\_(ツ)_/Β―
0
1
2
@padstamundo
Patrick Harris
4 years
Nice summary from @adm_stewart - lead author of the MERINO-2 trial, now published in OFID @IDSAInfo which tackles the thorny issue of PTZ for AmpC producers @UQMedicine @MerinoTrial
@adm_stewart
Adam Stewart
4 years
The recently published MERINO-2 trial in OFID is a pilot clinical trial which compares the use of piptaz to mero for treatment of bacteremia due to AmpC-producers. Correct interpretation of data and take-home messages are of great importance 1/
0
5
22
@ABsteward
Antibiotic Steward Bassam Ghanem πŸ…±οΈCπŸ†”πŸ…ΏοΈπŸŒŸ
4 years
πŸ†•πŸ’₯πŸ’₯ MERINO-2 #OFID Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp or Serratia marcescens https://t.co/6exOKwkGB9
9
136
355
@padstamundo
Patrick Harris
5 years
MERINO-3 Trial Protocol now published: Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to... - https://t.co/zXs2CFcsqz #ScholarAlerts @MerinoTrial @davidantibiotic @adm_stewart
0
37
104
@IDstewardship
Bug Pharmacist πŸ’ŠπŸ§« Tim Gauthier
5 years
New! πŸ“„πŸ₯³ It’s less about COVID than you might think. https://t.co/jhoCuXC8g0 Credit for this list goes to @ABsteward!!!
5
98
196
@MerinoTrial
MERINO Trial
5 years
More sheep in the paddock
@davidantibiotic
David Paterson
5 years
Out in CID - Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study @merinotrial @padstamundo
1
0
3
@davidvanduin
David van Duin
5 years
Dr. Tamma: MERINO-2 is a pilot RCT comparing pip/tazo vs meropenem for BSI 2nd to AmpC producers (species &genus details in slide @jpogue1 😊) Enrollment completed, awaiting results. @IDWeek2020 #idweek2020
2
7
47
@Josh_S_Davis
Joshua Davis
6 years
And here is my #top10papers in ID for 2019 in one slide if you can't be bothered reading the whole thread #IDtwitter. Happy new year!
8
175
360
@davidantibiotic
David Paterson
6 years
Coming very soon from @padstamundo and @MerinoTrial - a new RCT of #cefiderocol for hospital-acquired BSI, especially in settings of MBLs and other forms of carbapenem resistance.
1
33
69
@MerinoTrial
MERINO Trial
6 years
Interesting point-counterpoint discussion on the implications and interpretation of @MerinoTrial @davidantibiotic
1
21
43
@AbbyPDouglas
Abby Douglas
7 years
Lots of reference to the merino trial! Changing practice all around the world! Very proud Australian @MerinoTrial @padstamundo #ECCMID2019
0
7
30
@drdavidwjg
Dr David Griffin πŸ¦ πŸ§«πŸ’‰
7 years
@victoriahall26 @ESCMID @TAEscmid A really healthy trend in ID at the moment, with the OVIVA, @MerinoTrial, #camera2, #POET, 7 v 14 d for GNB, etc. ...Asking a question and answering it, with relatively limited funding, it seems!
0
1
9
@MerinoTrial
MERINO Trial
7 years
For anyone going to #ECCMID2019 we will be presenting some additional @MerinoTrial data on clinical outcome related to MICs (using BMD) and AMR genes. @padstamundo @davidantibiotic
1
26
82
@ABsteward
Antibiotic Steward Bassam Ghanem πŸ…±οΈCπŸ†”πŸ…ΏοΈπŸŒŸ
7 years
Best of 2018 Clinical Trials in ID According to my followers. @MerinoTrial. Congratulations @padstamundo and @davidantibiotic for a great study. More to expect in 2019. MERINO 2
@ABsteward
Antibiotic Steward Bassam Ghanem πŸ…±οΈCπŸ†”πŸ…ΏοΈπŸŒŸ
7 years
Which RCT/study of 2018 you believe is the most impactful/Practice changing in ID πŸ€” @NEJM @JAMA_current @MerinoTrial @IDSAInfo @padstamundo @davidantibiotic @accpinfdprn
0
9
28
@CarlosdelRio7
Carlos del Rio
7 years
⁦@JWatch⁩ Top 10 Infectious Diseases articles of 2018 as selected by the editors ⁦@Armstrws⁩ ⁦@RMKGandhi⁩
jwatch.org
1
21
44